Renovaro (FRA:2Q5) Total Long-Term Assets : €194.18 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Renovaro Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Renovaro's Total Long-Term Assets for the quarter that ended in Mar. 2024 was €194.18 Mil.

Renovaro Total Long-Term Assets Historical Data

The historical data trend for Renovaro's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renovaro Total Long-Term Assets Chart

Renovaro Annual Data

Trend

Mar13

Dec14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Long-Term Assets

Get a 7-Day Free Trial

148.13

150.22

140.03

71.02

51.45

Renovaro Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Long-Term Assets	Get a 7-Day Free Trial															69.87	51.45	52.15	51.00	194.18

Renovaro Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Renovaro Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Renovaro's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Renovaro (FRA:2Q5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Renovaro Inc (FRA:2Q5) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

RENB:USA 2Q5:Germany

Address

2080 Century Park East, Suite 906, Los Angeles, CA, USA, 90067

Website

https://www.enochianbio.com

Renovaro Biosciences Inc Formerly Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.

Renovaro (FRA:2Q5) Headlines

No Headlines